Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9Multiple Myeloma 5Neoplasms 4Neoplasm Metastasis 4Kidney Neoplasms 3Giant Cell Tumor of Bone 3Smoldering Multiple Myeloma 2Prostatic Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer Metastatic 1Recurrence 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Osteoblastoma 1Neoplastic Cells, Circulating 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Inflammatory Breast Neoplasms 1Hypercalcemia 1Humoral Hypercalcemia Of Malignancy 1Hodgkin Disease 1Head and Neck Neoplasms 1Granuloma, Giant Cell 1

Interventions

Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Bone Cysts, Aneurysmal × Denosumab × Clear all
NCT03605199 2019-08-26

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

Leiden University Medical Center

Phase 2 Unknown
60 enrolled

Chondroblastoma, Granuloma, Giant Cell, Bone Cysts, Aneurysmal, Osteoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡